XML 19 R8.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statements of Equity (Deficit) And Noncontrolling Interest - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Treasury Stock [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Parent [Member]
Noncontrolling Interest [Member]
Redeemable Noncontrolling Interest In Joint Venture [Member]
Total
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Transition adjustment related to adoption $ 550 $ 1,192,261 $ (18,467) $ (911,092) $ (57,951) $ 205,301 $ 14,516   $ 219,817
Beginning balance at Dec. 31, 2020 550 1,192,261 (18,467) (911,092) (57,951) 205,301 14,516   219,817
Beginning balance at Dec. 31, 2020               $ 100,969  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income (loss)       (104,521)   (104,521) (807)    
Net loss                 (105,328)
Net loss               (11,793)  
Other comprehensive income (loss), net of income taxes         6,100 6,100     6,100
Redemption of noncontrolling interest in Operating Partnership       (1,352)   (1,352) (1,086)   (2,438)
Contribution to consolidated joint venture               4,425  
Restricted stock units and stock options surrendered   (3,357)   12   (3,345)     (3,345)
Equity-based compensation expense   2,522       2,522     2,522
Ending balance at Mar. 31, 2021 550 1,191,426 (18,467) (1,016,953) (51,851) 104,705 12,623   117,328
Ending balance at Mar. 31, 2021               93,601  
Beginning balance at Dec. 31, 2020 550 1,192,261 (18,467) (911,092) (57,951) 205,301 14,516   219,817
Beginning balance at Dec. 31, 2020               100,969  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income (loss)                 (162,440)
Net loss                 (16,501)
Net loss                 (1,229)
Ending balance at Jun. 30, 2021 551 1,095,415 (18,467) (1,074,872) (40,647) (38,020) 12,201   (25,819)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Transition adjustment related to adoption 550 1,191,426 (18,467) (1,016,953) (51,851) 104,705 12,623   117,328
Beginning balance at Mar. 31, 2021 550 1,191,426 (18,467) (1,016,953) (51,851) 104,705 12,623   117,328
Beginning balance at Mar. 31, 2021               93,601  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income (loss)       (57,919)   (57,919) (422)   (57,919)
Net loss                 (58,341)
Net loss                 (4,708)
Net loss                 (422)
Net loss               (4,708)  
Other comprehensive income (loss), net of income taxes         11,204 11,204     11,204
Purchase of remaining interest in consolidated joint venture   (99,107)       (99,107)   (88,893) (99,107)
Restricted stock units and stock options surrendered 1 (50)       (49)     (49)
Equity-based compensation expense   3,146       3,146     3,146
Ending balance at Jun. 30, 2021 551 1,095,415 (18,467) (1,074,872) (40,647) (38,020) 12,201   (25,819)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Transition adjustment related to adoption 551 1,095,415 (18,467) (1,074,872) (40,647) (38,020) 12,201   (25,819)
Transition adjustment related to adoption 551 1,112,867 (18,467) (1,088,105) (29,080) (22,234) (159)   (22,393)
Beginning balance at Dec. 31, 2021 551 1,112,867 (18,467) (1,088,105) (29,080) (22,234) (159)   (22,393)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income (loss)       (24,621)   (24,621) (176)    
Net loss                 (24,797)
Other comprehensive income (loss), net of income taxes         9,986 9,986     9,986
Restricted stock units and stock options surrendered   (3,761)       (3,761)     (3,761)
Equity-based compensation expense   3,786       3,786     3,786
Ending balance at Mar. 31, 2022 551 1,112,892 (18,467) (1,112,726) (19,094) (36,844) (335)   (37,179)
Beginning balance at Dec. 31, 2021 551 1,112,867 (18,467) (1,088,105) (29,080) (22,234) (159)   (22,393)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income (loss)                 25,663
Net loss                 280
Net loss                 184
Ending balance at Jun. 30, 2022 552 1,106,955 (18,467) (1,062,442) (20,392) 6,206 25   6,231
Ending balance at Jun. 30, 2022               296,236 296,236
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Transition adjustment related to adoption 551 1,112,892 (18,467) (1,112,726) (19,094) (36,844) (335)   (37,179)
Beginning balance at Mar. 31, 2022 551 1,112,892 (18,467) (1,112,726) (19,094) (36,844) (335)   (37,179)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income (loss)       50,284   50,284 360   50,284
Net loss                 50,644
Net loss                 280
Net loss                 360
Net loss               280  
Other comprehensive income (loss), net of income taxes         (1,298) (1,298)     (1,298)
Sale of noncontrolling interest in OEG   (9,467)       (9,467)   295,956 (9,467)
Restricted stock units and stock options surrendered 1 (124)       (123)     (123)
Equity-based compensation expense   3,654       3,654     3,654
Ending balance at Jun. 30, 2022 552 1,106,955 (18,467) (1,062,442) (20,392) 6,206 25   6,231
Ending balance at Jun. 30, 2022               $ 296,236 296,236
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Transition adjustment related to adoption $ 552 $ 1,106,955 $ (18,467) $ (1,062,442) $ (20,392) $ 6,206 $ 25   $ 6,231